Multifocalidad y multicentricidad del cáncer de mama detectada por mamoresonancia en pacientes que acuden a un centro de salud, 2022 Multifocality and multicentricity of breast cancer detected by mammoresonance in patients attending a health center, 2022

• Parra, Irama ^[1] ; Moreno, Franklin ^[1]
  1. [1] Universidad de Los Andes

     Universidad de Los Andes

     Colombia

     
• Localización: GICOS: Revista del Grupo de Investigaciones en Comunidad y Salud, ISSN-e 2610-797X, Vol. 9, Nº. 3 (septiembre-diciembre), 2024, págs. 294-313
• Idioma: español
• Títulos paralelos:
  • Multifocality and multicentricity of breast cancer detected by mammoresonance in patients attending a health center, 2022
• Enlaces
  • Texto completo
• Resumen
  • español

    Objetivo: determinar la multicentricidad y multifocalidad por resonancia magnética en pacientes con cáncer de mama que asistieron al Servicio de Imagenología del Centro de Especialidades Médicas (CEDEM), durante el año 2022. Materiales y métodos: observacional correlacional, diseño no experimental, retrospectivo transversal, en pacientes recientemente diagnosticadas de CA de mama que acudieron a realizarse Resonancia Magnética de mama. Se analizaron las imágenes en conjunto con el diagnóstico histopatológico e inmunohistoquímico obtenido de la historia clínica de cada paciente. Resultados: Se analizó un total de 75 pacientes a quienes se les realizó resonancia magnética de mama; 40% resultó con presencia de multifocalidad y 23,3% de multicentricidad, coincidiendo un 20% de la muestra con presencia de CA MF/MC, siendo esta relación estadísticamente significativa (p<.001). En el estudio dinámico postcontraste de la resonancia magnética se evidenció predominio de la curva tipo II en un 94%. La mayoría correspondió a Carcinomas ductales infiltrantes, Luminales B. Conclusiones: La resonancia Magnética de mama permite determinar la presencia de multifocalidad y multicentricidad en el CA de Mama; esencial y determinante en la decisión del tratamiento a seguir, por lo que debe incluirse como valoración preoperatoria en las pacientes.Objective: to determine multicentricity and multifocality by magnetic resonance imaging in patients with breast cancer who attended the Imaging Service of the Center for Medical Specialties (CEDEM), during the year 2022. Materials and methods: Observational correlational, non-experimental, retrospective cross-sectional design, in patients recently diagnosed with breast CA who came to undergo breast MRI. The images were analyzed together with the histopathological and immunohistochemical diagnosis obtained from the medical history of each patient. Results: A total of 75 patients who underwent breast MRI were analyzed; 40% had multifocality and 23.3% had multicentricity, with 20% of the sample having MF/MC CA, this relationship being statistically significant (p <.001). In the post-contrast dynamic study of the magnetic resonance imaging, a predominance of the type II curve was evident in 94%. The majority corresponded to infiltrating ductal carcinomas, Luminal B. Conclusions: Breast magnetic resonance imaging allows determining the presence of multifocality and multicentricity in breast cancer; essential and determining in the decision of the treatment to follow, so it should be included as a preoperative assessment in patients.Recibido: 03-09-2024Aceptado: 11-10-2024Publicado: 01-11-2024

  • English

    Objective: to determine multicentricity and multifocality by magnetic resonance imaging in patients with breast cancer who attended the Imaging Service of the Center for Medical Specialties (CEDEM), during the year 2022. Materials and methods: Observational correlational, non-experimental, retrospective cross-sectional design, in patients recently diagnosed with breast CA who came to undergo breast MRI. The images were analyzed together with the histopathological and immunohistochemical diagnosis obtained from the medical history of each patient. Results: A total of 75 patients who underwent breast MRI were analyzed; 40% had multifocality and 23.3% had multicentricity, with 20% of the sample having MF/MC CA, this relationship being statistically significant (p <.001). In the post-contrast dynamic study of the magnetic resonance imaging, a predominance of the type II curve was evident in 94%. The majority corresponded to infiltrating ductal carcinomas, Luminal B. Conclusions: Breast magnetic resonance imaging allows determining the presence of multifocality and multicentricity in breast cancer; essential and determining in the decision of the treatment to follow, so it should be included as a preoperative assessment in patients.